Rocket Pharmaceuticals (RCKT) PT Raised to $41 at Baird, Added to Fresh Pick List

December 6, 2019 8:16 AM

Baird analyst Madhu Kumar raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $41.00 (from $30.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found